Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1606 to 1620 of 2026 results for nice guidelines

  1. Febuxostat for the management of hyperuricaemia in people with gout (TA164)

    This guidance has been updated and replaced by NICE guideline NG219.

    Withdrawn guidance

  2. The clinical effectiveness and cost effectiveness of anakinra for rheumatoid arthritis (TA72)

    This appraisal has been updated and replaced by NICE guideline CG79. 

    Withdrawn guidance

  3. Chronic kidney disease: managing anaemia (NG8)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline

  4. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

    This guidance has been updated and replaced by NICE guideline NG158.

    Withdrawn guideline

  5. Hypertension in pregnancy: diagnosis and management (CG107)

    This guidance has been updated and replaced by NICE guideline NG133

    Withdrawn guideline

  6. Neonatal infection (early onset): antibiotics for prevention and treatment (CG149)

    This guidance has been updated and replaced by NICE guideline NG195.

    Withdrawn guideline

  7. Crohn's disease: management (CG152)

    This guidance has been updated and replaced by NICE guideline NG129.

    Withdrawn guideline

  8. Ectopic pregnancy and miscarriage: diagnosis and initial management (CG154)

    This guidance has been updated and replaced by NICE guideline NG126

    Withdrawn guideline

  9. Epilepsies: diagnosis and management (CG137)

    This guidance has been updated and replaced by NICE guideline NG217.

    Withdrawn guideline

  10. Lung cancer: diagnosis and management (CG121)

    This guidance has been updated and replaced by NICE guideline NG122.

    Withdrawn guideline

  11. Chronic kidney disease (stage 5): peritoneal dialysis (CG125)

    This guidance has been updated and replaced by NICE guideline NG107.

    Withdrawn guideline

  12. Hypertension in adults: diagnosis and management (CG127)

    This guidance has been updated and replaced by NICE guideline NG136.

    Withdrawn guideline

  13. Colorectal cancer: diagnosis and management (CG131)

    This guidance has been updated and replaced by NICE guideline NG151.

    Withdrawn guideline

  14. Self-harm in over 8s: long-term management (CG133)

    This guidance has been updated and replaced by NICE guideline NG225.

    Withdrawn guideline

  15. Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline